MedTrace Logo

Evaluation of A Partially Hydrolyzed in Improving FGIDs Symptoms

NCT03390309 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-12

No results posted yet for this study

Summary

Evaluation of A Partially Hydrolyzed Whey Protein Infant Formula in Improving Functional Gastrointestinal Disorders (FGIDs) Symptoms

Conditions

  • Functional Gastrointestinal Disorders

Interventions

OTHER

Partially Hydrolyzed Formula

Partially Hydrolyzed Whey Protein Infant Formula

OTHER

Normal Formula

Normal Formula

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-05
Primary Completion
2018-12-30
Completion
2019-06-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390309 on ClinicalTrials.gov